Jan 3, 2019
Another blood pressure medication has been recalled over cancer-causing impurity
Posted by Genevieve Klien in category: biotech/medical
We had no shortage of blood pressure medication recalls in 2018, with multiple companies issuing warnings over drug impurities that could cause cancer. It looks like that trend will continue in 2019 as yet another company has issued a recall of blood pressure tablets after detecting an impurity that may be cancer-causing.
This time around it’s Aurobindo Pharma USA Inc, which is recalling prescriptions of the drug Valsartan, you may remember, has been the subject of recalls due to such impurities in the past. The drug is sold by several manufacturers, and in July of 2018 almost a half-dozen companies were forced to recall their products due to the discovery of human carcinogens in the tablets.